MARLTON, N.J., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced today it has received ...

MARLTON, N.J., June 14, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics, a commercial-stage medical device company focused on delivering our CCM therapy to people with heart failure, announced that the ...

MT. LAUREL, N.J.--(BUSINESS WIRE)--Impulse Dynamics, a medical device company dedicated to improving the lives of heart failure patients, today announced the publication of the FIX-HF-5C2 study in ...

Impulse Dynamics said Wednesday that it has raised $158 million to commercialize and further develop its heart failure treatment. The Food and Drug Administration approved Impulse's Optimizer system ...

MOUNT LAUREL, N.J.--(BUSINESS WIRE)--Impulse Dynamics, developer of the implantable Optimizer Smart System for delivering Cardiac Contractility Modulation (also known as CCM™ therapy), announced that ...

Investors are getting behind Impulse Dynamics’s implantable device that helps treat heart failure. The Mount Laurel, NJ-based company raised $80.3 million in a series D round – that will help give the ...

The Optimizer Smart implantable pulse generator, which delivers cardiac contractility modulation (CCM) therapy, is now approved by the US Food and Drug Administration for the treatment of chronic, ...

Impulse Dynamics has enrolled the first patient in a post-approval study of the Cardiac Contractility Modulation therapy, which is delivered by the Optimizer system. The move comes a few months after ...

BOSTON – Cardiologists have sought for decades to find a way to improve cardiac contractility, but progress has been slow in coming. The contractility problem for some heart failure patients may soon ...